胃十二指肠与胰十二指肠动脉瘤腔内治疗的临床结局
该单中心回顾性研究纳入2014年1月至2025年3月连续15例接受腔内治疗的胃十二指肠动脉(GDA)或胰十二指肠动脉(PDA)动脉瘤患者,评估技术成功、并发症及长期结局。结果显示技术成功率100%,无手术相关并发症,平均随访27.5个月无动脉瘤复发或再灌注。尽管腹腔干(CA)或肠系膜上动脉(SMA)狭窄常见,常规血运重建可能并非必要。
要点
- GDA/PDA动脉瘤腔内治疗技术成功率高,随访期无复发。
- CA或SMA狭窄常见,但常规血运重建可能并非必要。
- 无症状患者占多数,部分以腹痛起病,少数确诊时已破裂。
核心结论
- GDA和PDA动脉瘤的腔内治疗有效且持久。
- 尽管CA或SMA狭窄常见,常规血运重建可能并非必要。
研究设计与样本
- 单中心回顾性研究,连续纳入2014年1月至2025年3月接受腔内治疗的GDA或PDA动脉瘤患者15例。
- 分析数据包括人口学特征、临床表现、动脉瘤特征、技术成功、术后并发症及长期结局。
主要发现
- 13例(86.6%)患者检出CA狭窄,1例(6.6%)检出SMA狭窄,1例(6.6%)无CA或SMA狭窄。
- 10例(66.7%)诊断时无症状,5例(33.3%)表现为腹痛,其中2例确认动脉瘤破裂。
- 所有患者均行弹簧圈栓塞,2例附加支架置入(1例CA,1例SMA)以保留动脉血流。
- 技术成功率为100%,无手术相关并发症。
- 平均随访27.5个月,未观察到动脉瘤复发或再灌注。
临床怎么用
- 对于GDA或PDA动脉瘤,可考虑弹簧圈栓塞为主的腔内治疗。
- 存在CA或SMA狭窄时,不一定需要常规血运重建,可根据情况选择性置入支架。
局限性
- 单中心回顾性设计,样本量小(15例),随访时间平均27.5个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastroduodenal artery (GDA) and pancreaticoduodenal artery (PDA) aneurysms are rare visceral artery aneurysms associated with a high risk of rupture and life-threatening hemorrhage irrespective of size. Prompt diagnosis and appropriate management are therefore critical. This study aimed to evaluate the clinical outcomes of endovascular treatment for GDA and PDA aneurysms. METHODS: We retrospectively reviewed 15 consecutive patients who underwent endovascular treatment for GDA or PDA aneurysms at a single center between January 2014 and March 2025. Analyzed data included patient demographics, clinical presentation, aneurysm characteristics, technical success, postprocedural complications, and long-term outcomes. RESULTS: None of the patients had a history of pancreatitis, previous interventions, surgery, or trauma. Celiac artery (CA) stenosis was identified in 13 (86.6%) patients and superior mesenteric artery (SMA) stenosis in 1 (6.6%) patient; 1 (6.6%) patient had no stenosis of CA or SMA. In addition, 10 (66.7%) patients were asymptomatic at diagnosis, whereas 5 (33.3%) patients presented with abdominal pain. Among the symptomatic patients, 2 patients were confirmed to have ruptured aneurysms. All patients underwent coil embolization; additional stent placement was performed in 2 patients-one in the CA and one in the SMA-to preserve arterial flow. The technical success rate was 100%, with no procedure-related complications. Over a mean follow up of 27.5 months, no aneurysm recurrence or reperfusion was observed. CONCLUSION: Endovascular treatment for GDA and PDA aneurysms is effective and durable. Although CA or SMA stenosis is commonly observed, routine revascularization may not be necessary.
引用
- Kim S, Han Y, Gwon JG, et al. Clinical Outcomes of Endovascular Treatment for Gastroduodenal and Pancreaticoduodenal Artery Aneurysms. Ann Vasc Surg. 2026. PMID: 42462901. doi:10.1016/j.avsg.2026.06.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。